NATCO Pharma Ltd. (NATCOPHARM) closed at ₹821.95 on 19 Nov 2026, up 0.16 % on the day. It is unchanged over the past year; it stands 33.0 % below its 52-week high; it trades below its 200-day average. Its P/E is 12.9 on the last four quarters' profit. In Q1 FY27 (Apr-Jun 2026), profit fell 57.0 % and revenue fell 44.7 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.
Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance
The line uses prices adjusted for splits, bonuses and similar events.
Results in short
Q1 FY27 (Apr-Jun 2026), as the company reported it.
NATCO Pharma Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.